PMID: 7539922Jun 6, 1995Paper

Combinatorial association and abundance of components of interferon-stimulated gene factor 3 dictate the selectivity of interferon responses

Proceedings of the National Academy of Sciences of the United States of America
H A BluyssenD E Levy

Abstract

Genes containing the interferon-stimulated response element (ISRE) enhancer have been characterized as transcriptionally responsive primarily to type I interferons (IFN alpha/beta). Induction is due to activation of a multimeric transcription factor, interferon-stimulated gene factor 3 (ISGF3), which is activated by IFN alpha/beta but not by IFN gamma. We found that ISRE-containing genes were induced by IFN gamma as well as by IFN alpha in Vero cells. The IFN gamma response was dependent on the ISRE and was accentuated by preexposure of cells to IFN alpha, a treatment that increases the abundance of ISGF3 components. Overexpression of ISGF3 polypeptides showed that the IFN gamma response depended on the DNA-binding protein ISGF3 gamma (p48) as well as on the 91-kDa protein STAT91 (Stat1 alpha). The transcriptional response to IFN alpha required the 113-kDa protein STAT113 (Stat2) in addition to STAT91 and p48. Mutant fibrosarcoma cells deficient in each component of ISGF3 were used to confirm that IFN gamma induction of an ISRE reporter required p48 and STAT91, but not STAT113. A complex containing p48 and phosphorylated STAT91 but lacking STAT113 bound the ISRE in vitro. IFN gamma-induced activation of this complex, preferenti...Continue Reading

References

Jul 1, 1977·The Journal of General Virology·F L GrahamR Nairn
Aug 25, 1992·Proceedings of the National Academy of Sciences of the United States of America·C SchindlerJ E Darnell
Aug 25, 1992·Proceedings of the National Academy of Sciences of the United States of America·X Y FuJ E Darnell
Dec 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·R McKendryG R Stark
Jun 20, 1986·Cell·M ParkG F Vande Woude
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·L E ReidI M Kerr
Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·D LevyJ E Darnell
Sep 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·N ReichJ E Darnell

❮ Previous
Next ❯

Citations

Dec 18, 2001·European Journal of Immunology·Y HuangB W Winston
Apr 22, 1992·Biochimica Et Biophysica Acta·D GelvanP Saltman
Jun 1, 1996·Cytokine & Growth Factor Reviews·A R BluyssenD E Levy
Oct 11, 2003·Pharmacology & Therapeutics·Dhananjaya V Kalvakolanu
Apr 1, 1997·Current Opinion in Cell Biology·C M Horvath, J E Darnell
Mar 14, 2012·Immunology and Cell Biology·Nicole A de Weerd, Thao Nguyen
May 29, 2010·The Journal of Biological Chemistry·Leon GrayferMiodrag Belosevic
Aug 24, 2004·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Daniel T W ClarkeNigel A J McMillan
Mar 1, 1997·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·T DeckerA Meinke
Oct 22, 1998·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·T RonniI Julkunen
Nov 1, 2007·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·David B ShultzGeorge R Stark
Nov 26, 2009·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·David B ShultzGeorge R Stark
Jul 1, 1997·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·O SilvennoinenP Kovanen
Feb 6, 2008·Molecular and Cellular Biology·Padmaja GadeDhananjaya V Kalvakolanu
Oct 6, 1998·Annual Review of Biochemistry·G R StarkR D Schreiber
Jan 1, 1997·Annual Review of Immunology·U BoehmJ C Howard
Mar 13, 2001·Annual Review of Immunology·T TaniguchiN Tanaka
Mar 15, 2008·The Journal of Clinical Investigation·Donna L ThibaultPaul J Utz
Aug 3, 1999·Biological Chemistry·M MatsumotoT Taniguchi
Jun 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Hao-Ming ChangDavid E Levy
Feb 13, 2007·Proceedings of the National Academy of Sciences of the United States of America·Katrin RamsauerThomas Decker
Mar 19, 2016·Cytokine & Growth Factor Reviews·Tamara Suprunenko, Markus J Hofer
Dec 18, 2002·The Journal of Investigative Dermatology·Naoko Kanda, Shinichi Watanabe
Feb 27, 2003·The Journal of Investigative Dermatology·Naoko Kanda, Shinichi Watanabe
Oct 22, 2008·Cytokine & Growth Factor Reviews·Daniel J GoughChristopher J Clarke
Nov 30, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Myriam VilascoEliane F Meurs
Aug 21, 2013·Immunological Reviews·Russell K DurbinJoan E Durbin
Aug 27, 2014·International Journal of Cancer. Journal International Du Cancer·Iryna KolosenkoAngelo De Milito
Dec 20, 2007·The Journal of General Virology·Richard E Randall, Stephen Goodbourn
Aug 7, 2013·Developmental and Comparative Immunology·Jun ShiJian-Fang Gui
Mar 31, 2011·Biochimica Et Biophysica Acta·Cristina Isabel Santos, Ana P Costa-Pereira

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.